DOCGO ALERT: Bragar Eagel & Squire, P.C. is Investigating DocGo, Inc. on Behalf of DocGo Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against DocGo, Inc. (“DocGo” or the “Company”) (NASDAQ: DCGO) on behalf of DocGo stockholders. Our investigation concerns whether DocGo has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On January 10, 2024, before the market opened, Fuzzy Panda Research released a report entitled “DocGo – Allegations of Fraudulent Billing Practices & Forging of Documents.” Fuzzy Panda further stated that “through former employee interviews and never before seen lawsuits we discovered serious allegations that DocGo (DCGO) has allegedly been committing Medicare fraud and having employees forge signatures on medical documents.”
On this news, the price of DocGo stock fell sharply in intraday trading on January 10, 2024.
If you purchased or otherwise acquired DocGo shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com
Previous Posts:
- ENSERVCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Enservco Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- TuSimple ALERT: Bragar Eagel & Squire, P.C. is Investigating TuSimple Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- BRIGHT HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Bright Health Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Next Posts:
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Driven, and Maison Solutions and Encourages Investors to Contact the Firm
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Golden Heaven, and Inspire Medical and Encourages Investors to Contact the Firm
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm